Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Letter:</i> Consider a Low-Metal Diet in Metal-Allergic Dyshidrotic Eczema Patients Prior to Advanced Systemic Therapy.

Dermatitis : contact, atopic, occupational, drug·2025

Same author

Is Food-Triggered Atopic Dermatitis a Form of Systemic Contact Dermatitis?

Clinical reviews in allergy & immunology·2024

Same author

Stasis Dermatitis: The Burden of Disease, Diagnosis, and Treatment.

Dermatitis : contact, atopic, occupational, drug·2023

Same author

Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management.

American journal of clinical dermatology·2023

Same author

Association of Food Insecurity With Atopic Dermatitis: A Cross-sectional Analysis of a National Sample of Pediatric Patients.

Dermatitis : contact, atopic, occupational, drug·2022

Same author

Transcriptomic Profiling of Plaque Psoriasis and Cutaneous T-Cell Subsets during Treatment with Secukinumab.

JID innovations : skin science from molecules to population health·2022

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

Patch testing for adverse drug reactions.

Sahil Sekhon¹, Susan T Nedorost¹

¹Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Ohio, USA.

|February 17, 2017

Summary

This summary is machine-generated.

Diagnosing adverse drug reactions is challenging due to the lack of safe testing. This review focuses on patch testing as a diagnostic tool for drug allergies, presenting new research findings.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Minimal Erythema Dose MED Testing

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

Related Experiment Videos

Last Updated: Mar 7, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Minimal Erythema Dose MED Testing

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

Area of Science:

Clinical immunology
Dermatology
Pharmacology

Background:

Adverse drug reactions (ADRs) are a significant cause of hospitalizations.
Current diagnostic methods lack a safe gold standard, relying on clinical judgment or risky oral rechallenge.
Existing tests like skin prick tests and lymphocyte transformation tests have limitations.

Purpose of the Study:

To review the utility of patch testing for diagnosing adverse drug reactions.
To present novel data on the efficacy of patch testing in drug allergy evaluation.

Main Methods:

Review of existing literature on patch testing for ADRs.
Presentation of new clinical data and case studies involving patch testing.

Main Results:

Patch testing demonstrates potential as a safe and effective diagnostic method for certain ADRs.
New data supports the role of patch testing in identifying specific drug culprits.
Comparison with other diagnostic modalities highlights patch testing's advantages.

Conclusions:

Patch testing offers a valuable, safer alternative to oral rechallenge for diagnosing drug hypersensitivity.
Further research and data are needed to establish patch testing as a routine diagnostic standard for ADRs.